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Since 1983, the Centers for Disease Control and
Prevention have been providing healthcare practi-
tioners with guidelines based on evidence for the
prevention of catheter-related infection. This latest
report was developed by a working group represent-
ing various organizations and disciplines from the
fields of infection control, critical care medicine,
infectious disease, surgery, anesthesiology, inter-
ventional radiology, pulmonary medicine, pediatric
medicine, and nursing. As per the previous guide-
lines published in 1983 and 1996, each recommen-
dation is categorized based on existing scientific
data, theoretical rationale, applicability, and eco-
nomic impact. The categories are listed as follows:
Category IA—strongly recommended for implemen-
tation and strongly supported by well-designed
experimental, clinical, or epidemiologic studies; Cat-
egory IB—strongly recommended for implementa-
tion and supported by some experimental, clinical,
or epidemiologic studies, and a strong theoretical
rationale; Category IC—required by state or federal
regulations, rules, or standards; Category II—sug-
gested for implementation and supported by sugges-
tive clinical or epidemiologic studies or a theoretical
rationale; and Unresolved Issue—an unresolved
issue for which evidence is insufficient or no consen-
sus regarding efficacy exists.
In the past, the guidelines were intended for use
in hospitals and acute care with the recommenda-
tion of adapting them for use in home care and
outpatient areas. They are now recommended to be
used across the health continuum. Overall, the
guidelines are much easier to read. The working
group placed catheter types into their respective
categories instead of listing them separately. For
instance, peripheral venous catheter recommenda-
tions incorporate midline catheter information, and
central venous catheter recommendations include
peripherally inserted central catheters (PICC),
hemodialysis, and pulmonary artery catheters. The
paper also has two appendices for reference pur-
poses. One contains examples of clinical and surveil-
lance definitions for primary bloodstream infection
(BSI), and the second is a summary of the recom-
mended frequency for the replacement of catheters,
dressings, administration sets, and fluids. There are
major areas that have been included into the paper.
These include the following: (1) suggestions for per-
formance indicators that organizations can monitor
to reduce the incidence of catheter-related blood-
stream infection (Category IA); (2) the use of maxi-
mal sterile barrier precautions inclusive of mask,
cap, sterile gown, sterile gloves, and large sterile
sheet for the insertion and guidewire changes of
central venous catheters (CVCs), including PICCs
(Category IA); (3) preference of a 2% chlorhexidine-
based preparation for insertion and catheter site
care, although tincture of iodine and iodophor or
70% alcohol may be used (Category IA); (4) the use of
antimicrobial- or antiseptic-impregnated catheters
should be used in adults whose catheters are to
remain in place for 5 days if the institution’s BSI
rate is greater than benchmark rates and if other
infection control measures have failed (Category
IB); (5) central catheters and midline catheters
should not be routinely replaced to decrease the risk
of infection (Category IB); and (6) the importance of
educational programs and competency testing for
clinicians responsible for the insertion and care of
venous catheters (Category IA).
Evidence-based documentation in refereed jour-
nals and clinical competencies has demonstrated
that specially trained personnel decrease the poten-
tial for catheter-related bloodstream infections
(CRBSI). In the guidelines there is a lengthy discus-
sion concerning the morbidity and mortality of
patients requiring central venous access and the
substantial financial burden CRBSI places on the
healthcare system. Numerous studies have demon-
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strated that the incidence of BSI is higher in inten-
sive care units than in other patient care settings.
These new guidelines have made two exciting rec-
ommendations regarding these historical issues.
The first is the inclusion of the importance of appro-
priate nursing staff levels in intensive care units to
minimize the risk of CRBSI (Category IB). The
second is the recommendation for IV personnel des-
ignated for the insertion and maintenance of intra-
vascular catheters (Category IA).
Nutrition support clinicians will find that the
recommendations remain largely unchanged con-
cerning parenteral nutrition. One port (if using a
multilumen catheter) should be used for the admin-
istration of parenteral nutrition. Lipid-containing
parenteral nutrition fluids (ie, 3-in-1 solutions)
should be completed within 24 hours of hanging the
fluid, and the infusion of lipid emulsions alone
should be completed with 12 hours of hanging the
fluid. There continues to be no recommendation for
the hang time of non–lipid-containing fluids. IV
tubing sets used to administer lipid emulsions
should be changed within 24 hours of initiating the
infusion. One recommendation that went from an
Unresolved Issue to a Category II is the administra-
tion tubing for parenteral nutrition solutions con-
taining only dextrose and amino acids does not need
to be changed more frequently than every 72 hours.
When determining how to integrate these guide-
lines into your organization, clinicians should be
reminded that these are just what they are stated
to be—guidelines. Each organization must take
into account other benchmarking data provided by
other professional organizations, your organiza-
tion’s experience, cost/benefit analysis, and results
from continued research that is evolving in this
area. Only then can you determine what is best for
your practice.
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